EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

SYNTHESIS AND PRECLINICAL EVALUATION OF NOVEL CHALCONE-DERIVED HYBRIDS AS DUAL-ACTION ANTIMALARIAL AND ANTI-INFLAMMATORY AGENTS

Syed Mohammad Sufyan, Aisha Rafique, Muhammad Waqar Rafique, Muhammad Zakria, Maida Aslam, Sadeeq Ullah

Insights-Journal of Life and Social Sciences · 15.12.2025 · 4 (2) · 182-189

DOI: 10.71000/vkbg3c21 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Insights-Journal of Life and Social Sciences, online erschienen am 15.12.2025. Verfasst von Syed Mohammad Sufyan und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Malaria remains a major global health burden, with severe forms such as cerebral malaria contributing significantly to mortality and long-term neurological complications. While existing antimalarial therapies are effective in reducing parasite load, they often fail to adequately address the host-driven inflammatory responses that underlie severe disease manifestations. This therapeutic gap highlights the need for multifunctional agents capable of targeting both parasitic infection and inflammation-related pathology.

Objective

The study aimed to develop and preclinically evaluate novel chalcone-derived hybrid compounds with dual antimalarial and anti-inflammatory activity, focusing on parasite clearance and modulation of inflammation relevant to cerebral involvement. Methods:A descriptive preclinical study was conducted over two months in Dera Ghazi Khan. Novel chalcone-derived hybrids were synthesized and structurally characterized using standard spectroscopic techniques. Antimalarial activity was assessed through in vitro Plasmodium falciparum growth inhibition assays, while anti-inflammatory effects were evaluated using cytokine profiling and histopathological assessment in an established inflammatory model. Data were analyzed using parametric statistical tests, with significance set at p < 0.05.

Results

The synthesized compounds demonstrated varying degrees of antimalarial efficacy, with the most active hybrid achieving parasite inhibition comparable to the reference drug and exhibiting a low IC₅₀ value. Treated groups showed marked reductions in tumor necrosis factor-α and interleukin-6 levels compared to controls. Histopathological findings supported these results, revealing significantly reduced inflammatory changes in brain tissue among treated groups. A strong inverse correlation was observed between parasite inhibition and inflammatory marker levels.

Conclusion

Chalcone-derived hybrid compounds exhibited promising dual-action effects by effectively inhibiting parasite growth and attenuating inflammation-associated responses. These findings supported the potential of multifunctional chalcone-based agents as candidates for further preclinical development targeting both infection and inflammation in malaria.

Zitieren

APA

Sufyan, S. M., Rafique, A., Rafique, M. W., Zakria, M., Aslam, M., & Ullah, S. (2025). SYNTHESIS AND PRECLINICAL EVALUATION OF NOVEL CHALCONE-DERIVED HYBRIDS AS DUAL-ACTION ANTIMALARIAL AND ANTI-INFLAMMATORY AGENTS. Insights-Journal of Life and Social Sciences, 4(2), 182-189. https://doi.org/10.71000/vkbg3c21

Vancouver

Sufyan SM, Rafique A, Rafique MW, Zakria M, Aslam M, Ullah S. SYNTHESIS AND PRECLINICAL EVALUATION OF NOVEL CHALCONE-DERIVED HYBRIDS AS DUAL-ACTION ANTIMALARIAL AND ANTI-INFLAMMATORY AGENTS. Insights-Journal of Life and Social Sciences. 2025;4(2):182-189. doi:10.71000/vkbg3c21

BibTeX
@article{Sufyan2025,
  author = {Sufyan, Syed Mohammad and Rafique, Aisha and Rafique, Muhammad Waqar and Zakria, Muhammad and Aslam, Maida and Ullah, Sadeeq},
  title = {SYNTHESIS AND PRECLINICAL EVALUATION OF NOVEL CHALCONE-DERIVED HYBRIDS AS DUAL-ACTION ANTIMALARIAL AND ANTI-INFLAMMATORY AGENTS},
  journal = {Insights-Journal of Life and Social Sciences},
  year = {2025},
  volume = {4},
  number = {2},
  pages = {182--189},
  doi = {10.71000/vkbg3c21}
}
Kostenlos starten →